3 Reasons to Sell CoreWeave Stock Before It's Too late

CoreWeave, a GPU-focused cloud provider for training and running LLMs, reported Q3 revenue of $1.36 billion, up 134% year‑over‑year, but operating margins collapsed from 20% to 4% and operating income fell to $52.8 million. The company trades at a P/S of 8.3 (versus Nvidia's 24 and the S&P 500 average of 3.3), carries $10.3 billion in non‑current debt against $1.9 billion cash with $310.6 million of interest expense in Q3, and the article warns that slowing generative‑AI progress and aggressive pricing undermine CoreWeave's ability to justify its valuation.

Analysis

Market structure: Winners are asset-light hardware/control-point owners (NVDA, large hyperscalers, data‑center REITs like EQIX) who control GPU supply and pricing; losers are specialized GPU cloud resellers with high leverage (CRWV) facing margin compression from price competition. Pricing power will concentrate with Nvidia and hyperscalers as they throttle supply or bundle software, forcing smaller operators into discounting or consolidation; expect spot GPU rental rates to remain volatile for 3–12 months.

Risk assessment: Key tail risks include a rapid improvement in model efficiency (reducing FLOPS demand by >20%), export controls on advanced GPUs, or a refinancing shock given CRWV’s $10.3bn non‑current debt vs $1.9bn cash and $310.6m Q3 interest run‑rate — any missed covenant/refinancing in the next 12–18 months could be existential. Time horizons split: immediate (days–weeks) credit spread and implied‑vol spikes, short term (0–6 months) margin erosion from price competition, long term (1–3+ years) structural demand tied to AI model progress.

Trade implications: Direct trade: tactical short CRWV sized 1–2% of portfolio with a 3–12 month horizon, target $28.7 (implied P/S 3.3) and 20% stop; pair trade long NVDA vs short CRWV (delta‑adjusted) 6–12 months to capture dispersion in fundamentals. Options: buy 3–6 month CRWV puts (strike near $30–35) to asymmetrically capture downside and buy NVDA 9–15 month calls (or Jan‑2026 LEAPs) for convex exposure to sustained AI demand; reduce exposure to mid/small‑cap AI infra names and shift 2–4% to utilities/REITs exposed to data‑center power (EQIX/NEE).

Contrarian angles: Consensus overlooks a realistic M&A outcome — hyperscalers or private equity could buy CRWV at a premium to avoid capacity loss; probability low but would cap downside and create squeeze risk. Also underappreciated: short‑term price competition may accelerate consolidation, creating longer‑term winners with higher margins; monitor GPU spot pricing, CRWV refinancing announcements within 90 days, and any reported >20% improvements in model compute efficiency as binary catalysts.

Key Decisions for Investors

• Initiate a tactical short in CRWV sized 1–2% of portfolio with a 3–12 month horizon; set target $28.7 (≈60% downside from prior levels) and stop‑loss 20% above entry. Rationale: stretched valuation, collapsing operating margin (4% vs 20%), and $10.3bn non‑current debt vs $1.9bn cash.
• Establish a relative‑value pair: long NVDA (1–2% position) vs short CRWV (dollar‑neutral, delta‑adjusted) for 6–12 months to capture concentration of pricing power in Nvidia/hyperscalers.
• Buy CRWV 3–6 month puts (strike ~$30–35) sized to 0.5–1% portfolio risk to capture near‑term downside from credit/refinancing shocks; simultaneously buy NVDA 9–15 month calls or Jan‑2026 LEAPs (1% allocation) for asymmetric upside to sustained AI demand.
• Rotate 2–4% from speculative small/mid‑cap AI infrastructure names into data‑center exposed REITs/utilities (e.g., EQIX, NEE) and large diversified cloud vendors (AMZN, MSFT) to hedge power/capex risk while preserving AI exposure.
• Monitor three binary triggers before increasing size: (1) any CRWV refinancing announcement or equity raise within 90 days (reduces downside), (2) material Nvidia GPU price/supply changes reported in next 30–90 days, and (3) published research indicating >20% reduction in model compute per token — treat any as catalyst to reassess positions.